Mathys is committed to motion worldwide. Founded in 1946, the company has been active in medical technology since 1958 and focuses on the development, manufacture and distribution of joint replacement products. The company's services include implants for hip, knee, shoulder and sports orthopaedics, and synthetic bone graft substitute. Headquartered in Bettlach, Switzerland, Mathys has development and production sites in Switzerland and Germany, as well as subsidiaries in 11 countries, and has been part of the US-based company Enovis™ since 2021. Enovis is committed to measurably improving patient outcomes by developing specialised solutions to clinical problems.